市場調査レポート
商品コード
1380286
分子生物学用酵素・キット・試薬市場:タイプ、用途、エンドユーザー別-2023~2030年、年世界予測Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
分子生物学用酵素・キット・試薬市場:タイプ、用途、エンドユーザー別-2023~2030年、年世界予測 |
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
分子生物学用酵素・キット・試薬市場は、2022年の171億8,000万米ドルから2030年には420億2,000万米ドルに達すると予測され、予測期間中のCAGRは11.82%です。
分子生物学用酵素・キット・試薬の世界市場
主な市場の統計 | |
---|---|
市場金額:基準年[2022年] | 171億8,000万米ドル |
推定市場金額[2023年] | 191億4,000万米ドル |
予測市場金額[2030年] | 420億2,000万米ドル |
CAGR(%) | 11.82% |
FPNVポジショニングマトリックスは分子生物学用酵素・キット・試薬市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。洞察により、意思決定者は自信を持って市場をナビゲートすることができます。
市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。
1.市場の浸透度:主要企業の市場力学と製品に関する包括的な情報を提供します。
2.市場の開拓度:新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。
3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。
4.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。
5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。
1.分子生物学用酵素・キット・試薬市場の市場規模および予測は?
2.分子生物学用酵素・キット・試薬市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は?
3.分子生物学用酵素・キット・試薬市場における競争戦略枠組みとは?
4.分子生物学用酵素・キット・試薬市場の最新技術動向と規制の枠組みは?
5.分子生物学用酵素・キット・試薬市場における主要ベンダーの市場シェアは?
6.分子生物学用酵素・キット・試薬市場への参入に適した形態や戦略的手段は?
The Molecular Biology Enzymes & Kits & Reagents Market is projected to reach USD 42.02 billion by 2030 from USD 17.18 billion in 2022, at a CAGR of 11.82% during the forecast period.
Global Molecular Biology Enzymes & Kits & Reagents Market
KEY MARKET STATISTICS | |
---|---|
Base Year Value [2022] | USD 17.18 billion |
Estimated Year Value [2023] | USD 19.14 billion |
Forecast Year Value [2030] | USD 42.02 billion |
CAGR (%) | 11.82% |
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Molecular Biology Enzymes & Kits & Reagents Market.
Based on Type, market is studied across Enzymes, Kits, and Reagents. The Enzymes is further studied across DNA Polymerases, Ligases, and Restriction Enzymes. The Kits is further studied across DNA Sequencing Kits, PCR Kits, and RNA Extraction Kits. The Reagents is further studied across Buffers, Dyes, Nucleotides, Primers, and Stains. The Reagents is projected to witness significant market share during forecast period.
Based on Application, market is studied across Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction, and Sequencing. The Drug Discovery & Development is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Research institutions, Diagnostic Centers, Hospitals, and Pharma & Biotech Companies. The Pharma & Biotech Companies is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is an indispensable tool for assessing the Molecular Biology Enzymes & Kits & Reagents Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
The Market Share Analysis offers invaluable insights into the vendor landscape Molecular Biology Enzymes & Kits & Reagents Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
The report delves into recent significant developments in the Molecular Biology Enzymes & Kits & Reagents Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Agilent Technologies, Inc., Bio Basic Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fortis Life Sciences, Illumina, Inc., Jena Bioscience GmbH, Krishgen Biosystems, LGC Limited, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Molecular Biology Resources, Inc., New England Biolabs, Inc., PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Rockland Immunochemicals, Inc., Sartorius AG, Takara Holdings Inc., Thermo Fisher Scientific Inc., and Zymo Research Corporation.
1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast for the Molecular Biology Enzymes & Kits & Reagents Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Molecular Biology Enzymes & Kits & Reagents Market?
3. What is the competitive strategic window for identifying opportunities in the Molecular Biology Enzymes & Kits & Reagents Market?
4. What are the latest technology trends and regulatory frameworks in the Molecular Biology Enzymes & Kits & Reagents Market?
5. What is the market share of the leading vendors in the Molecular Biology Enzymes & Kits & Reagents Market?
6. Which modes and strategic moves are suitable for entering the Molecular Biology Enzymes & Kits & Reagents Market?